Pascrell Votes to Strengthen American Health Care
House passed bill lowers drug costs and fights back against Republican sabotage of the ACA
Washington, May 16, 2019
Tags: Health Care
Today, U.S. Rep. Bill Pascrell, Jr. (D-NJ-09) celebrated the House passage of H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act. The bill will strengthen health care options, reverse Republican sabotage of the Affordable Care Act (ACA), rescind the Trump administration’s destructive junk insurance plan rule, and promote competition in the prescription drug marketplace.
“Americans elected the new House to provide a careful balance of oversight combined with an aggressively positive agenda. With today’s vote, the House is fighting back against Donald Trump and Republicans’ repeated attempts to destroy the ACA and weaken health care for millions,” stated Rep. Pascrell. “Furthermore, for too long, Americans and their families strangled by high drug prices have cried out for their elected leaders to lower prices. Our legislation delivers reforms to ease that burden.”
The package of legislation passed today includes Rep. Andy Kim’s (D-NJ-03) State Allowance for a Variety of Exchanges, or SAVE Act. This bipartisan bill would ease the transition to state-based marketplaces (SBM) for many states like New Jersey that currently participate in the federally-facilitated exchange and plan to move to an SBM. Switching to an SBM helps states achieve higher enrollment and lower premiums compared to the federally-facilitated marketplace.
Breakdown of H.R. 987
Reducing drug prices is dependent upon allowing generics to come to market quickly after patent and exclusivity periods end. The legislation closes loopholes that drugs companies exploit. Additionally, elements of the bill include:
Additionally, H.R. 987 is compromised of several elements dedicated to making health care more affordable and reversing the Trump administration’s ongoing sabotage of the ACA, negative actions that have raised premiums and out-of-pocket costs for Americans.